Don't Just Read the News, Understand It.
Published loading...Updated

What Is Addyi? The Controversy Behind the Drug Nicknamed the 'Female Viagra' - MedShadow Foundation | Independent Health & Wellness Journalism

Summary by MedShadow
Approved in 2015 after two FDA rejections, Addyi is marketed as a breakthrough for low libido in women amid controversy and safety concerns
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MedShadow broke the news in on Friday, June 6, 2025.
Sources are mostly out of (0)